These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33495337)

  • 41. Acetaminophen attenuates doxorubicin-induced cardiac fibrosis via osteopontin and GATA4 regulation: reduction of oxidant levels.
    Schunke KJ; Coyle L; Merrill GF; Denhardt DT
    J Cell Physiol; 2013 Oct; 228(10):2006-14. PubMed ID: 23526585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paraquat neurotoxicity is mediated by the dopamine transporter and organic cation transporter-3.
    Rappold PM; Cui M; Chesser AS; Tibbett J; Grima JC; Duan L; Sen N; Javitch JA; Tieu K
    Proc Natl Acad Sci U S A; 2011 Dec; 108(51):20766-71. PubMed ID: 22143804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA‑133b alleviates doxorubicin‑induced cardiomyocyte apoptosis and cardiac fibrosis by targeting PTBP1 and TAGLN2.
    Li Z; Ye Z; Ma J; Gu Q; Teng J; Gong X
    Int J Mol Med; 2021 Jul; 48(1):. PubMed ID: 33982775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo disposition of doxorubicin is affected by mouse Oatp1a/1b and human OATP1A/1B transporters.
    Durmus S; Naik J; Buil L; Wagenaar E; van Tellingen O; Schinkel AH
    Int J Cancer; 2014 Oct; 135(7):1700-10. PubMed ID: 24554572
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tetrandrine Attenuated Doxorubicin-Induced Acute Cardiac Injury in Mice.
    Li G; Li WR; Jin YG; Jie QQ; Wang CY; Wu L
    Biomed Res Int; 2020; 2020():2616024. PubMed ID: 32461972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of OAT1/OAT3 as Contributors to Cisplatin Toxicity.
    Hu S; Leblanc AF; Gibson AA; Hong KW; Kim JY; Janke LJ; Li L; Vasilyeva A; Finkelstein DB; Sprowl JA; Sweet DH; Schlatter E; Ciarimboli G; Schellens J; Baker SD; Pabla N; Sparreboom A
    Clin Transl Sci; 2017 Sep; 10(5):412-420. PubMed ID: 28689374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity.
    Anjos M; Fontes-Oliveira M; Costa VM; Santos M; Ferreira R
    Life Sci; 2021 Sep; 280():119760. PubMed ID: 34166713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy.
    Efentakis P; Varela A; Chavdoula E; Sigala F; Sanoudou D; Tenta R; Gioti K; Kostomitsopoulos N; Papapetropoulos A; Tasouli A; Farmakis D; Davos CH; Klinakis A; Suter T; Cokkinos DV; Iliodromitis EK; Wenzel P; Andreadou I
    Cardiovasc Res; 2020 Mar; 116(3):576-591. PubMed ID: 31228183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p.
    Yu X; Ruan Y; Shen T; Qiu Q; Yan M; Sun S; Dou L; Huang X; Wang Q; Zhang X; Man Y; Tang W; Jin Z; Li J
    Biomed Res Int; 2020; 2020():5107193. PubMed ID: 32190669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Foxo3a inhibits mitochondrial fission and protects against doxorubicin-induced cardiotoxicity by suppressing MIEF2.
    Zhou L; Li R; Liu C; Sun T; Htet Aung LH; Chen C; Gao J; Zhao Y; Wang K
    Free Radic Biol Med; 2017 Mar; 104():360-370. PubMed ID: 28137654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice.
    Ma ZG; Kong CY; Wu HM; Song P; Zhang X; Yuan YP; Deng W; Tang QZ
    Theranostics; 2020; 10(24):11013-11025. PubMed ID: 33042267
    [No Abstract]   [Full Text] [Related]  

  • 52. miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway.
    Yin Z; Zhao Y; Li H; Yan M; Zhou L; Chen C; Wang DW
    Aging (Albany NY); 2016 Jan; 8(1):192-207. PubMed ID: 26837315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased Soluble Guanylate Cyclase Contributes to Cardiac Dysfunction Induced by Chronic Doxorubicin Treatment in Mice.
    Vandenwijngaert S; Swinnen M; Walravens AS; Beerens M; Gillijns H; Caluwé E; Tainsh RE; Nathan DI; Allen K; Brouckaert P; Bartunek J; Scherrer-Crosbie M; Bloch KD; Bloch DB; Janssens SP; Buys ES
    Antioxid Redox Signal; 2017 Feb; 26(4):153-164. PubMed ID: 27505125
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiR-15b-5p is Involved in Doxorubicin-Induced Cardiotoxicity via Inhibiting Bmpr1a Signal in H9c2 Cardiomyocyte.
    Wan GX; Cheng L; Qin HL; Zhang YZ; Wang LY; Zhang YG
    Cardiovasc Toxicol; 2019 Jun; 19(3):264-275. PubMed ID: 30535663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity.
    Burridge PW; Li YF; Matsa E; Wu H; Ong SG; Sharma A; Holmström A; Chang AC; Coronado MJ; Ebert AD; Knowles JW; Telli ML; Witteles RM; Blau HM; Bernstein D; Altman RB; Wu JC
    Nat Med; 2016 May; 22(5):547-56. PubMed ID: 27089514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72.
    Kavazis AN; Smuder AJ; Min K; Tümer N; Powers SK
    Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1515-24. PubMed ID: 20833957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway.
    Hu C; Zhang X; Song P; Yuan YP; Kong CY; Wu HM; Xu SC; Ma ZG; Tang QZ
    Redox Biol; 2020 Oct; 37():101747. PubMed ID: 33045622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hydrogen-Rich Saline Attenuates Cardiac and Hepatic Injury in Doxorubicin Rat Model by Inhibiting Inflammation and Apoptosis.
    Gao Y; Yang H; Fan Y; Li L; Fang J; Yang W
    Mediators Inflamm; 2016; 2016():1320365. PubMed ID: 28104928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity.
    Reynolds JG; Geretti E; Hendriks BS; Lee H; Leonard SC; Klinz SG; Noble CO; Lücker PB; Zandstra PW; Drummond DC; Olivier KJ; Nielsen UB; Niyikiza C; Agresta SV; Wickham TJ
    Toxicol Appl Pharmacol; 2012 Jul; 262(1):1-10. PubMed ID: 22676972
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Cardioprotective Effect of Metformin in Doxorubicin-Induced Cardiotoxicity: The Role of Autophagy.
    Zilinyi R; Czompa A; Czegledi A; Gajtko A; Pituk D; Lekli I; Tosaki A
    Molecules; 2018 May; 23(5):. PubMed ID: 29762537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.